 
                Chemical Structure : IN-1130
CAS No.: 868612-83-3
Catalog No.: PC-70054Not For Human Use, Lab Use Only.
IN-1130 is a potent, highly selective ALK5 inhibitor, inhibits the purified kinase domain of ALK5-mediated Smad3 phosphorylation with an IC50 of 5.3 nM.
| Packing | Price | Stock | Quantity | 
|---|---|---|---|
| 5 mg | $78 | In stock | |
| 10 mg | $118 | In stock | |
| 25 mg | $218 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote | 
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	IN-1130 is a potent, highly selective ALK5 inhibitor, inhibits the purified kinase domain of ALK5-mediated Smad3 phosphorylation with an IC50 of 5.3 nM.
	IN-1130 is highly selective in a panel of 27 serine/threonine and tyrosine kinases including p38α.
	IN-1130 decreases levels of TGF-beta1 mRNA, type I collagen mRNA, and pSmad2, compared to UUO control rats.
	IN-1130 inhibits renal fibrosis in obstructive nephropathy in vivo models.
| M.Wt | 420.47 | |
| Formula | C25H20N6O | |
| Appearance | Solid | |
| Storage | 
 | 
 | 
| Solubility | 10 mM in DMSO | |
| Chemical Name/SMILES | Benzamide, 3-[[4-(6-methyl-2-pyridinyl)-5-(6-quinoxalinyl)-1H-imidazol-2-yl]methyl]- (9CI) | |
1. Moon JA, et al. Kidney Int. 2006 Oct;70(7):1234-43.
2. Ryu JK, et al. J Sex Med. 2009 May;6(5):1284-96.
3. Park CY, et al. Cancer Lett. 2014 Aug 28;351(1):72-80.

 
                 
                 
                 
                 
                 
                 
                 
                 
            
            
        Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright